PAHC Earnings & Financial Statements
Phibro Animal Health Corporation
$32.96
-$2.44(-6.89%)
62
Overall
90
Value
45
Tech
52
Quality
Market Cap
$1.34B
Volume
283.68K
52W Range
$28.25 - $60.08
Target Price
$50.00
PAHC earnings and financial statements: Phibro Animal Health Corporation's income statement, balance sheet and cash flow statement, annual and quarterly.
PAHC Annual Financial Statements
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $1.52B | $1.30B | $1.02B | $977.89M | $942.26M |
| Cost of revenue | $1.01B | $896.27M | $704.59M | $679.65M | $656.86M |
| Operating income | $194.40M | $110.47M | $53.31M | $71.85M | $78.99M |
| EBITDA | $232.96M | $150.22M | $66.67M | $104.13M | $117.72M |
| Net income | $99.72M | $48.26M | $2.42M | $32.61M | $49.17M |
| EPS (diluted) | $2.43 | $1.19 | $0.06 | $0.81 | $1.21 |
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total assets | $1.50B | $1.36B | $982.18M | $971.40M | $931.70M |
| Total liabilities | $1.12B | $1.08B | $725.54M | $688.89M | $669.26M |
| Shareholders’ equity | $385.48M | $285.68M | $256.64M | $282.51M | $262.44M |
| Cash and equivalents | $61.42M | $68.04M | $70.61M | $41.28M | $74.25M |
| Long-term debt | $753.17M | $702.43M | $458.29M | $452.54M | $417.93M |
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating cash flow | $68.95M | $80.12M | $87.59M | $13.31M | $31.65M |
| Capital expenditure | -$59.09M | -$38.29M | -$41.24M | -$51.79M | -$37.04M |
| Free cash flow | $9.87M | $41.83M | $46.36M | -$38.48M | -$5.39M |
| Dividends paid | $19.46M | $19.45M | $19.44M | $19.44M | $19.44M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PAHC | $32.96 | -6.9% | 283.68K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Phibro Animal Health Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW